Celecoxib for the prevention of nonmuscle invasive bladder cancer: results from a matched control study

Celecoxib for the prevention of nonmuscle invasive bladder cancer: results from a matched control study

Objectives: New targets and approaches are under investigation for the treatment of nonmuscle invasive bladder cancer (NMIBC). Preclinical data suggest cyclooxygenase-2 (COX-2) as a promising target. Celecoxib, a COX-2 selective inhibitor, inhibits tumor development and enhances survival, both in vi...

Full description

Bibliographic Details
Main Authors: Vincenzo Pagliarulo, Patrizia Ancona, Ivan Martines, Rossana Spadavecchia, Savino Di Stasi, Stefano Alba, Luigi Cormio, Caterina Fanizza, Annamaria Salerno, Giuseppe Carrieri, Arcangelo Pagliarulo
Format: Article
Language:English
Published: SAGE Publishing 2015-12-01
Series:Therapeutic Advances in Urology
Online Access:https://doi.org/10.1177/1756287215599695

Internet

https://doi.org/10.1177/1756287215599695

Similar Items